Clinical Trials on Pulmonary Aspiration

Total 15774 results

Brasilia University Hospital

Unknown

Gastric Emptying of Maltodextrin Solution in Elderly and in Adults (GEMA)

Fasting | Aspiration; Liquids | Perioperative Pulmonary Aspiration

Brazil
University of Calgary
Alberta Health services

Not yet recruiting

Semaglutide and Preoperative Residual Gastric Volumes

Pulmonary Aspiration

Canada
The University of Texas Health Science Center,...

Completed

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Pulmonary Aspiration

United States
University of Malaya

Completed

To Compare Effect of Sevoflurane Versus Desflurane on the Return of Swallowing Reflexes in the Elderly

Pulmonary Aspiration

Malaysia
University of Modena and Reggio Emilia

Not yet recruiting

Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis (NASA)

Fibrosis, Pulmonary
Vendsyssel Hospital

Completed

Gastric Volume After Drinking 175 ml of Ice Water Prior to Gastroscopy in Healthy Adult Patients

Fasting | Perioperative Pulmonary Aspiration

Denmark
Ajou University School of Medicine

Completed

Effect of Paratracheal Esophagus Pressure on the Insertion of Laryngeal Mask Airway

General Anesthesia | Pulmonary Aspiration

Korea, Republic of
Zhujiang Hospital

Completed

Effects of Combined Cycle Training and Inspiratory Muscle Training in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

China
West Park Healthcare Centre

Completed

Unsupported Arm Exercise and Breathing Strategy in Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Canada
Schön Klinik Berchtesgadener Land
University of Osnabrueck

Completed

The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV

Chronic Obstructive Pulmonary Disease

Germany
Faculdade Evangelica do Parana

Completed

Inspiratory Muscle Training in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease
Niigata University Medical & Dental Hospital

Completed

SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study

Pulmonary Alveolar Proteinosis, Autoimmune

Japan
Indonesia University

Completed

Effectivity of Inspiratory Muscle Trainer in the Chronic Obstructive Pulmonary Disease Rehabilitation Program

Chronic Obstructive Pulmonary Disease

Indonesia
Schön Klinik Berchtesgadener Land

Unknown

The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2

Chronic Obstructive Pulmonary Disease

Germany
Hôpital Riviera-Chablais, Vaud-Valais

Unknown

Inspiratory Muscle Training Combined With General Exercise Training in COPD (IMTGET)

Chronic Obstructive Pulmonary Disease
Alkermes, Inc.

Completed

ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Hospital de Clinicas de Porto Alegre

Completed

Activity of Inspiratory Muscles With the Use of Positive Pressure in Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
GlaxoSmithKline

Completed

Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Ukraine, Spain, South Africa, Italy
GlaxoSmithKline

Completed

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Japan, Poland, Romania, Russian Federation, Ukraine, Taiwan, Bulgaria, South Africa, Korea, Republic of
Boehringer Ingelheim

Completed

Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Roberto Tonelli

Active, not recruiting

Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study (IERATIC)

Idiopathic Pulmonary Fibrosis
Biosplice Therapeutics, Inc.

Withdrawn

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

Australia, New Zealand
Boehringer Ingelheim

Completed

Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline

Completed

Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

Pulmonary Disease, Chronic Obstructive

United States, Germany, Spain, Netherlands, Canada
GlaxoSmithKline

Completed

A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, Romania, Russian Federation, United States, Ukraine
GlaxoSmithKline

Completed

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Germany, Poland, Romania, United States, Czechia, Russian Federation
Boehringer Ingelheim

Completed

Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline

Completed

Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison

Pulmonary Disease, Chronic Obstructive

Belgium
Vectura, Inc.
Syneos Health

Terminated

Study to Compare the Pharmacokinetics and Pharmacodynamics of ASA Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Adult Subjects With Obstructive or Restrictive Pulmonary Function

Obstructive Pulmonary Function | Restrictive Pulmonary Function

United States
GlaxoSmithKline
University Hospital, Antwerp

Completed

Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients

Idiopathic Pulmonary Fibrosis

Belgium
Elpen Pharmaceutical Co. Inc.

Completed

A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method. (INSPIRE)

Pulmonary Disease

Greece
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects

Chronic Obstructive Pulmonary Disease

China
GlaxoSmithKline

Completed

Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry

Pulmonary Disease, Chronic Obstructive

Belgium
Wuerzburg University Hospital

Completed

Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery

Respiratory Insufficiency | Atelectasis | Pulmonary Infection | Bronchospasm | Aspiration Pneumonitis

Germany
Dokuz Eylul University

Completed

The Effect of Inspiratory Muscle Warm-Up in Patients With COPD

Chronic Obstructive Pulmonary Disease | COPD

Turkey
Minnesota HealthSolutions
Mayo Clinic

Completed

Mindful Breathing Awareness Through Pursed-Lip Breathing Training

Chronic Obstructive Pulmonary Disease

United States
University Hospital, Brest

Completed

Inspiratory Muscle Training During Pulmonary Rehabilitation in COPD (EMI II)

Chronic Obstructive Pulmonary Disease

France
Novartis Pharmaceuticals

Completed

Effect of Indacaterol on Inspiratory Capacity (IC)

Chronic Obstructive Pulmonary Disease

Germany
University Hospital, Brest
Ministry of Health, France

Completed

Effects of Inspiratory Muscle Training on Dyspnea in Subjects With Chronic Obstructive Pulmonary Disease (IMT)

Chronic Obstructive Pulmonary Disease

France
University Hospital, Essen

Completed

Effects of Breathing Retraining in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

Germany
Brno University Hospital

Recruiting

Inspiratory Muscle Training and COPD

Chronic Obstructive Pulmonary Disease

Czechia
Zhujiang Hospital

Completed

Acute Effects of Incremental Inspiratory Loads on Respiratory Mechanics and NRD in Patient With Stable COPD.

Chronic Obstructive Pulmonary Disease

China
Theravance Biopharma
Viatris Inc.

Completed

Phase 4 COPD and Suboptimal Inspiratory Flow Rate (PIFR-2)

Chronic Obstructive Pulmonary Disease

United States
Hospital Nossa Senhora da Conceicao

Completed

Spontaneous Breathing Trials Using Pressure-Support or T-Tube in Chronic Obstructive Pulmonary Disease Patients Weaning Mechanical Ventilation

Chronic Obstructive Pulmonary Disease | Weaning of Mechanical Ventilation

Brazil
Hospital General Universitario Gregorio Marañon
Ministry of Health, Spain

Completed

Inflammatory Response Secondary Using Intravenous Anesthesia Versus Inhalation Anesthesia With Halogenated Agents

Pulmonary Resection

Spain
Boehringer Ingelheim

Completed

Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Ankara City Hospital Bilkent

Completed

Ultrasound for Prediction of Empty Stomach in Infants

Anesthesia | Children, Only | Pulmonary Aspiration | Fasting

Turkey
GlaxoSmithKline

Completed

A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))

Pulmonary Disease, Chronic Obstructive

France, Germany, Spain, Russian Federation, Belgium, Ukraine, Philippines, Italy, Poland

3

Subscribe